**Chapter 4**

*Peptide Synthesis*

[15] Hamada Y. Recent progress in prodrug design strategies based on generally applicable modifications. Bioorganic & Medicinal Chemistry Letters. 2017;**27**:1627-1632. DOI: 10.1016/j.bmcl.2017.02.075

[23] Taniguchi A, Sohma Y, Kimura M, et al. "Click peptide" based on the "O-acyl isopeptide method": Control of Aβ1−42 production from a phototriggered Aβ<sup>1</sup>−42 analogue. Journal of the American Chemical Society. 2006;**128**:696-697. DOI: 10.1021/

[24] Yoshiya T, Sohma Y, Hamada Y, et al. Racemization-free segment condensation based on the O-acyl isopeptide method: Toward a chemical protein synthesis on solid support. Advances in Experimental Medicine and Biology. 2009;**611**:161-162. DOI: 10.1007/978-0-387-73657-0\_73

ja057100v

[16] Hamada Y, Kiso Y. Aspartic protease inhibitors as drug candidates for treating various difficult-to-treat diseases. In: Amino Acids, Peptides and Proteins. Vol. 39. London: Royal Society

of Chemistry; 2015. pp. 114-147

[17] Strickley RG. Solubilizing excipients in oral and injectable

formulations. Pharmaceutical Research. 2004;**21**:201-230. DOI: 10.1023/B:P HAM.0000016235.32639.23

[18] Panov I, Drabina P, Hanusek J, et al. Stereoselective synthesis of the key intermediates of the HIV protease inhibitor fosamprenavir and its diastereomer. Synlett. 2013;**24**:1280- 1282. DOI: 10.1055/s-0033-1338803

[19] Nguyen J-T, Hamada Y, Kimura T, et al. Design of potent aspartic protease inhibitors to treat various diseases. Archiv der Pharmazie—Chemistry in Life Sciences. 2008;**341**:523-535. DOI:

[20] Hamada Y, Kiso Y. The application of bioisosteres in drug design for novel drug discovery: Focusing on acid protease inhibitors. Expert Opinion on Drug Discovery. 2012;**7**:903-922. DOI:

[21] Hamada Y, Kiso Y. New directions for protease inhibitors directed drug discovery. Biopolymers. 2016;**106**: 563-579. DOI: 10.1002/bip.22780

[22] Hurley TR, Colson CE, Hicks G, et al. Orally active water-soluble N,O-acyl transfer products of α,β,γbishydroxyl amide containing renin inhibitor. Journal of Medicinal Chemistry. 1993;**36**:1496-1498. DOI:

10.1021/jm00062a024

10.1002/ardp.200700267

10.1517/17460441.2012.712513

**42**
